Gregorio Millett

Gregorio Millett, M.P.H.
Vice President and Director, Public Policy

Gregorio (Greg) Millett  is Vice President and Director of amfAR’s Public Policy Office. Mr. Millett is a former senior scientist with the Centers for Disease Control and Prevention as well as a former Senior Policy Advisor in the White House Domestic Policy Council, where he helped author and implement President Obama’s National HIV/AIDS Strategy. 

Mr. Millett is nationally recognized for his scientific research on health inequities as well as HIV prevention. He has multiple first author publications in top medical, public health and policy journals, including JAMA, Lancet, Health Affairs, and AJPH (American Journal of Public Health), has published with Dr. Anthony Fauci, and has been a plenary speaker at marquee HIV research conferences such as CROI (Conference on Retroviruses and Opportunistic Infections) and the International AIDS Conference. His major contributions to the scientific literature include publishing the first definitive meta-analysis showing that circumcision does not confer population-level HIV prevention benefit for gay and bisexual men (JAMA, 2008); empirically proving that social determinants and lack of healthcare access drive higher HIV rates among Black communities rather than risk behavior (AJPH, 2006 AIDS, 2007; Lancet, 2012); and providing the first evidence nationally that COVID-19 disproportionately affected Black and Latino communities earlier in the pandemic (Annals of Epidemiology, 2020). Mr. Millett’s research has been cited  over 10,000 times in the scientific literature as well as highlighted in major periodicals such as the New York Times, Washington Post, and the Wall Street Journal He is also a member of the editorial staff of two AIDS journals.

At amfAR, Mr. Millett leads a multidisciplinary team focused on preserving federal funding for domestic and global HIV programs and research. His team has won awards and recognition for using data to create dashboards that help policymakers, journalists, scientists, and advocates understand policy gaps in the opioid epidemic response, implementation of PEPFAR (the U.S. President’s Emergency Plan for AIDS Relief), and the COVID-19 pandemic response. He and his team have also produced policy analyses that have been central to preserving both CDC HIV prevention and PEPFAR funding. Mr. Millett currently serves on the scientific advisory board for PEPFAR and is a current member of both the International AIDS Society’s Governing Council as well as its Executive Board.

He is an alumnus of Dartmouth College and the University of North Carolina, Chapel Hill.